Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,670.00    20.00 (0.35%)
Bid:
5,670.00
Ask:
5,680.00
Spread: 10.00 (0.176%)
Market Cap: £3.04b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Director/PDMR Shareholding

3 Aug 2018 12:21

RNS Number : 8022W
Cranswick PLC
03 August 2018
 

Director/PDMR Shareholding

Cranswick plc ("the Company")

The Company has been notified that the following award of LTIP nil-cost options has been made, pursuant to the Cranswick plc Long Term Incentive Plan (the "Scheme"), to certain Directors/Persons Discharging Managerial Responsibility ("PDMR") over ordinary shares of 10 pence each in the Company ("Ordinary Shares"), as follows:

Name

No. of Ordinary Shares subject to Option

Martin Davey

19,100

Adam Couch

38,600

Mark Bottomley

25,500

Jim Brisby

25,500

Chris Aldersley

15,800

The nil-cost options were granted on 1 August 2018 in accordance with the Scheme and are based on a share price of 3293.34 pence per Ordinary Share, being the average quoted market price of the Company's shares on the three dealing days prior to the date of grant.

Each person has also been granted a tax qualifying option over 910 Ordinary Shares at an exercise price of 3293.34 pence per Ordinary Share as part of their award. These tax qualifying options are linked to the LTIP nil-cost options such that, at the time of exercise, to the extent that there is a gain in the tax qualifying option, the LTIP nil-cost option will be forfeited to the value of that gain.

Vesting of the LTIP nil-cost options and tax qualifying options is subject to the achievement of the performance criteria based on growth in EPS (as regards 50% of the awards) and relative Total Shareholder Return (as regards 50% of each award). The targets applying to each element are as follows.

 

Target

EPS

Threshold

Average annual % growth in RPI + 3%

Maximum

Average annual % growth in RPI + 9%

TSR

Threshold

Median

Maximum

Upper decile

 

Enquiries:

Steven Glover, Company Secretary tel: 01482 372000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEAFPDEAEPEFF
Date   Source Headline
3rd Jun 20263:37 pmRNSDirector/PDMR Shareholding
1st Jun 20268:41 amRNSTotal Voting Rights
26th May 202610:27 amRNSDirector/PDMR Shareholding
22nd May 20263:39 pmRNSDirector/PDMR Shareholding
21st May 20263:27 pmRNSDirectors Dealing
19th May 20267:00 amRNSPreliminary Results
13th May 202611:03 amRNSIssue of Equity/Admission to Trading
1st May 202611:53 amRNSTotal Voting Rights
22nd Apr 20266:05 pmRNSDirector/PDMR Shareholding
1st Apr 20263:44 pmRNSTotal Voting Rights
31st Mar 202612:33 pmRNSIssue of Equity/Admission to Trading
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 202610:37 amRNSDirector/PDMR Shareholding
24th Mar 202610:37 amRNSDirector/PDMR Shareholding
23rd Mar 202610:31 amRNSDirector/PDMR Shareholding
12th Mar 202612:07 pmRNSHolding(s) in Company
10th Mar 20264:47 pmRNSHolding(s) in Company
4th Mar 20265:17 pmRNSHolding(s) in Company
2nd Mar 20263:24 pmRNSHolding(s) in Company
2nd Mar 20263:21 pmRNSTotal Voting Rights
2nd Mar 20263:21 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:21 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:18 pmRNSDirector/PDMR Shareholding
26th Feb 20263:55 pmRNSHolding(s) in Company
24th Feb 202611:31 amRNSDirector/PDMR Shareholding
18th Feb 20265:55 pmRNSHolding(s) in Company
18th Feb 202612:11 pmRNSHolding(s) in Company
2nd Feb 20263:54 pmRNSTotal Voting Rights
30th Jan 20266:10 pmRNSHolding(s) in Company
30th Jan 20267:00 amRNSHolding(s) in Company
28th Jan 20265:59 pmRNSHolding(s) in Company
27th Jan 20267:00 amRNSThird quarter trading statement
23rd Jan 202611:27 amRNSDirector/PDMR Shareholding
22nd Jan 20264:51 pmRNSHolding(s) in Company
22nd Jan 20263:17 pmRNSHolding(s) in Company
19th Jan 20267:00 amRNSHolding(s) in Company
5th Jan 202610:52 amRNSTotal Voting Rights
23rd Dec 202512:48 pmRNSDirector/PDMR Shareholding
23rd Dec 202512:48 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20257:00 amRNSHolding(s) in Company
22nd Dec 202511:33 amRNSDirector/PDMR Shareholding
22nd Dec 202511:33 amRNSDirector/PDMR Shareholding
19th Dec 20253:18 pmRNSHolding(s) in Company
19th Dec 20253:18 pmRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20259:15 amRNSHolding(s) in Company
1st Dec 202510:49 amRNSTotal Voting Rights
25th Nov 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.